The week of 2025-12-22, 11 holders filed a new Schedule 13D and 27 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-12-23 | One & one Green Technologies. INC | Caifen Yan | 53.99% | SCHEDULE 13D |
| 2025-12-22 | Black Rock Coffee Bar, Inc. | Viking Cake BR, LLC | 53.1% | SCHEDULE 13D |
| 2025-12-22 | BUUU Group Ltd | BUBI Services Ltd | 51.73% | SCHEDULE 13D |
| 2025-12-23 | AIFU Inc. | Ileana Zhao | 38.69% | SCHEDULE 13D |
| 2025-12-22 | Crane Harbor Acquisition Corp. II | Crane Harbor Sponsor II, LLC | 25.8% | SCHEDULE 13D |
| 2025-12-22 | Twelve Seas Investment Co III | Twelve Seas Sponsor LLC | 25.6% | SCHEDULE 13D |
| 2025-12-22 | TORM plc | Hafnia Ltd | 13.97% | SCHEDULE 13D |
| 2025-12-23 | Manulife Private Credit Plus Fund | John Hancock Stable Value Advantage Trust | 13% | SCHEDULE 13D |
| 2025-12-23 | Vor Biopharma Inc. | ForGrowth III PA B.V. | 9.99% | SCHEDULE 13D |
| 2025-12-22 | Lakeland Industries Inc | Global Value Investment Corporation | 8.38% | SCHEDULE 13D |
| 2025-12-22 | Big Digital Energy, Inc. | Endeavor Blockchain, LLC | 5.3% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2025-12-22 | Brera Holdings PLC | Electric Capital Partners, LLC | 15.2% | SCHEDULE 13G |
| 2025-12-22 | Gloo Holdings, Inc. | Jesus Fund | 12.3% | SCHEDULE 13G |
| 2025-12-23 | Hyperliquid Strategies Inc. | Rorschach Advisors LLC | 9.99% | SCHEDULE 13G |
| 2025-12-22 | In8bio, Inc. | Stonepine Capital Management, LLC | 9.9% | SCHEDULE 13G |
| 2025-12-22 | SkyAI, Inc. | Electric Capital Partners, LLC | 9.9% | SCHEDULE 13G |
| 2025-12-23 | DEFSEC Technologies Inc. | Lind Global Fund III LP | 9.9% | SCHEDULE 13G |
| 2025-12-23 | RedHill Biopharma Ltd. | YA II PN, Ltd. | 9.9% | SCHEDULE 13G |
| 2025-12-23 | Founder Group Ltd | Streeterville Capital LLC | 9.9% | SCHEDULE 13G |
| 2025-12-23 | Milestone Pharmaceuticals Inc. | Propel Bio Management, LLC | 9.9% | SCHEDULE 13G |
| 2025-12-23 | Lipocine Inc. | Squadron Capital Management LLC | 9% | SCHEDULE 13G |
| 2025-12-22 | CapsoVision, Inc | Shen Ching Hang | 8.5% | SCHEDULE 13G |
| 2025-12-22 | Actelis Networks, Inc. | L1 Capital Global Opportunities Master Fund, Ltd. | 7.8% | SCHEDULE 13G |
| 2025-12-23 | Tenax Therapeutics, Inc. | Perceptive Advisors LLC | 7% | SCHEDULE 13G |
| 2025-12-23 | Forte Biosciences, Inc. | Affinity Asset Advisors, LLC | 6.9% | SCHEDULE 13G |
| 2025-12-23 | Iron Horse Acquisition II Corp. | Linden Advisors LP | 6.4% | SCHEDULE 13G |
| 2025-12-22 | American Drive Acquisition Company | Tenor Capital Management Company, L.P. | 6.3% | SCHEDULE 13G |
| 2025-12-23 | Eightco Holdings Inc. | Pantera Capital Partners LP | 6.22% | SCHEDULE 13G |
| 2025-12-22 | Elauwit Connection, Inc | Lytton Laurence W | 5.9% | SCHEDULE 13G |
| 2025-12-22 | Health Catalyst, Inc. | CDC Financial, Inc. | 5.5% | SCHEDULE 13G |
| 2025-12-22 | Launchpad Cadenza Acquisition Corp I | Tenor Capital Management Company, L.P. | 5.4% | SCHEDULE 13G |
| 2025-12-23 | ASTROTECH Corp | Skylark Partners I, LP | 5.4% | SCHEDULE 13G |
| 2025-12-23 | Churchill Capital Corp XI | Millennium Management LLC | 5.3% | SCHEDULE 13G |
| 2025-12-23 | Camtek Ltd. | Harel Insurance Investments & Financial Services Ltd | 5.3% | SCHEDULE 13G |
| 2025-12-23 | Cardinal Infrastructure Group Inc | Ophir Asset Management Pty Ltd | 5.3% | SCHEDULE 13G |
| 2025-12-23 | LeonaBio, Inc. | Anders Hove | 5.2% | SCHEDULE 13G |
| 2025-12-22 | American Drive Acquisition Company | MMCAP International Inc. SPC | 5% | SCHEDULE 13G |
| 2025-12-23 | Evolution Global Acquisition Corp | Linden Advisors LP | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.